|
|
Symposium 39 - Molecular Targeted Therapy for Cancer
Tuesday, September 19, 2006 14:00 - 17:30
|
|
Moderators:
|
Dr. Robert Yoshiyuki Osamura and Dr. Allen M. Gown
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. Dr. Kenneth Hillan indicated he is an employee and major share holder at Genentech, Inc. All other faculty members for this Symposium have indicated they have no disclosures to make.
|
Click any blue section number below to display text and references for individual lectures:
| Oncodiagnostic for Molecular Targeted Therapy
Robert Y. Osamura and Allen M.Gown |
| Oncodiagnostics: The Role of the Pathologist in Targeted Tumor Therapies
Allen M. Gown |
| Molecular Targeted Therapy for Neuroendocrine Tumors (NETs)
Robert Y. Osamura |
| Molecular Diagnostics in the Development and the Use of Novel Cancer Therapeutics
Gerald Batist |
| Her2/neu Testing in Breast Cancer
Wedad Hanna |
|
|
|
|
